On May 15, 2013, the signing ceremony of capital increase and share expansion between Wuhan HUST Life Science and Technology Co., Ltd. and Tianjin Haoyang Biological Manufacture Co., Ltd. was held in Tianjin Huigao Garden Hotel.

HUSTLIFE SCITECH will inject capital into TBD to assist it in developing new products, consolidating its technology advantage on cell separation, purification and culture products in the field of cell therapy.  

The leaders of Tianjin Food and Drug Administration and Chinese Academy of Medical Science Institute of Biomedical Engineering attended the signing ceremony.